These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17436713)

  • 21. Cost-efficacy of individual and combined treatments for panic disorder.
    McHugh RK; Otto MW; Barlow DH; Gorman JM; Shear MK; Woods SW
    J Clin Psychiatry; 2007 Jul; 68(7):1038-44. PubMed ID: 17685740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maintenance treatment for old-age depression preserves health-related quality of life: a randomized, controlled trial of paroxetine and interpersonal psychotherapy.
    Dombrovski AY; Lenze EJ; Dew MA; Mulsant BH; Pollock BG; Houck PR; Reynolds CF
    J Am Geriatr Soc; 2007 Sep; 55(9):1325-32. PubMed ID: 17767673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diagnosis and treatment of panic disorder].
    Saarijärvi S
    Duodecim; 1991; 107(2):116-20. PubMed ID: 1364744
    [No Abstract]   [Full Text] [Related]  

  • 24. Locus of control orientation in panic disorder and the differential effects of treatment.
    Bakker A; Spinhoven P; van der Does AJ; van Balkom AJ; van Dyck R
    Psychother Psychosom; 2002; 71(2):85-9. PubMed ID: 11844944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
    Sheehan DV; McElroy SL; Harnett-Sheehan K; Keck PE; Janavs J; Rogers J; Gonzalez R; Shivakumar G; Suppes T
    J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Venlafaxine and tardive blepharospasm: a case report.
    Lee Y; Yeh WC; Chong MY; Lin PY; Chang YY
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1139-40. PubMed ID: 17478026
    [No Abstract]   [Full Text] [Related]  

  • 27. Persistent tardive rebound panic disorder, rebound anxiety and insomnia following paroxetine withdrawal: a review of rebound-withdrawal phenomena.
    Bhanji NH; Chouinard G; Kolivakis T; Margolese HC
    Can J Clin Pharmacol; 2006; 13(1):e69-74. PubMed ID: 16456219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High plasma concentrations of paroxetine impede clinical response in patients with panic disorder.
    Watanabe T; Ueda M; Saeki Y; Hirokane G; Morita S; Okawa M; Akiyama K; Shimoda K
    Ther Drug Monit; 2007 Feb; 29(1):40-4. PubMed ID: 17304148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of paroxetine in treating major depressive disorder in persons with multiple sclerosis.
    Ehde DM; Kraft GH; Chwastiak L; Sullivan MD; Gibbons LE; Bombardier CH; Wadhwani R
    Gen Hosp Psychiatry; 2008; 30(1):40-8. PubMed ID: 18164939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repetitive transcranial magnetic stimulation (rTMS) in a patient suffering from comorbid depression and panic disorder following a myocardial infarction.
    Sakkas P; Psarros C; Papadimitriou GN; Theleritis CG; Soldatos CR
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):960-2. PubMed ID: 16631291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Practice guideline for the treatment of patients with panic disorder. Work Group on Panic Disorder. American Psychiatric Association.
    Am J Psychiatry; 1998 May; 155(5 Suppl):1-34. PubMed ID: 9585731
    [No Abstract]   [Full Text] [Related]  

  • 32. Two cases of deep vein thrombosis associated with a combined paroxetine and zotepine therapy.
    Pantel J; Schröder J; Eysenbach K; Mundt C
    Pharmacopsychiatry; 1997 May; 30(3):109-11. PubMed ID: 9211574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive behavioral group therapy in panic disorder patients: the efficacy of CBGT versus drug treatment.
    Dannon PN; Gon-Usishkin M; Gelbert A; Lowengrub K; Grunhaus L
    Ann Clin Psychiatry; 2004; 16(1):41-6. PubMed ID: 15147112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Once-daily duloxetine 60 mg in the treatment of major depressive disorder: multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil.
    Lee P; Shu L; Xu X; Wang CY; Lee MS; Liu CY; Hong JP; Ruschel S; Raskin J; Colman SA; Harrison GA
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):295-307. PubMed ID: 17472599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Citalopram-associated spontaneous ejaculations.
    Virit O; Savas HA
    J Clin Psychopharmacol; 2008 Jun; 28(3):360-1. PubMed ID: 18480704
    [No Abstract]   [Full Text] [Related]  

  • 36. Demographic and clinical features of panic disorder comorbid with bipolar I disorder: a 3-year retrospective study.
    Nardi AE; Nascimento I; Freire RC; Veras AB; de-Melo-Neto VL; Valença AM; Lopes FL; Soares-Filho GL; Levitan MN; de Carvalho MR; da Costa RT; King AL; Mezzasalma MA; Grivet LO; Rassi A; Versiani M
    J Affect Disord; 2008 Feb; 106(1-2):185-9. PubMed ID: 17604118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depression and psoriasis comorbidity. Treatment with paroxetine: two case reports.
    Luis Blay S
    Ann Clin Psychiatry; 2006; 18(4):271-2. PubMed ID: 17162628
    [No Abstract]   [Full Text] [Related]  

  • 38. Cognitive style, alprazolam plasma levels, and treatment response in panic disorder.
    Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
    Depress Anxiety; 2008; 25(8):E18-26. PubMed ID: 17960759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Dyspnoea of a young male patient].
    Zaitsev I
    Duodecim; 1996; 112(5):437, 445. PubMed ID: 10592606
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy of cognitive-behavioral therapy for comorbid panic disorder with agoraphobia and generalized anxiety disorder.
    Labrecque J; Marchand A; Dugas MJ; Letarte A
    Behav Modif; 2007 Sep; 31(5):616-37. PubMed ID: 17699121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.